Stay updated on platform news and potential beta tests.

Regular

Greg Moss, Chief Corporate Strategy and Legal Officer at Evommune, discusses the steps of developing a biopharma startup’s business strategy and landscape.

Images from Cure Tuesday Talks What Sets Successful Biotech Companies Apart with Greg Moss

Cure Tuesday Talks banner image Greg Moss 

This exciting initiative is set to make a significant impact on the startup ecosystem, offering valuable opportunities for growth and innovation. 

The Xchange prize for startups is up and running!

Tuesday Talks: What Sets Successful Biotech Companies Apart

Seema Kumar 

Chief Corporate Strategy and Legal Officer, Corporate Secretary and Chief Compliance Officer, Evommune, Inc.